Media-OutReach Newswire Zuellig Pharma Strengthens Consumer Healthcare Portfolio with the Acquisition of Zam-Buk® and Vapex® Brands from Bayer
Việt Nam targets growth of at least 10 per cent in 2027 while safeguarding macroeconomic stability 5.